Tylenol parent Kenvue stock bounces back after White House assault

thestreet.com/investing/tylenol-parent-kenvue-stock-bounces-back-after-white-house-assault

Tylenol maker Kenvue is looking to claw back some of the losses it took after the White House's long-awaited announcement about autism and ADHD.
Kenvue (KVUE) lost 7.47% of its stock value on Sept. 22's session after President Donald Trump and Secretary of Health and Human Services…

This story appeared on thestreet.com, 2025-09-23 16:37:00.
The Entire Business World on a Single Page. Free to Use →